AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

Analysts warn mega-merger risks undermine AstraZeneca’s growth and innovation strategy

Black News Black News
Aug 3, 2026 - 14:12
AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks
Analysts warn mega-merger risks undermine AstraZeneca’s growth and innovation strategy
Read More African Business News